AIM: £2.99 (+0.06) | Nasdaq: $18.49 (+0.43)
Search
EN
简
繁
About Us
Overview
Corporate Information
Board of Directors
Senior Management
Contact Us
Innovation Platform
Overview
R&D Approach
Our Pipeline
Key Corporate Partnerships
Innovation News
Commercial Platform
Overview
Competitive Advantages
Prescription Drugs
Consumer Health
Main Products
Commercial Platform News
News & Presentations
Recent News
All RNS & Press Releases
Presentations & Publications
Financial Results
Overview
Chairman's Statement
Financial Highlights
Financial Reports
SEC Filings
Shareholder Information
Overview
Events, Circulars & Forms
Share Price & Chart
Major Shareholders
Analyst Coverage
Dual-listing FAQs
Information for Shareholders
Warning to Shareholders
Terms of Reference & Policies
AIM Rule 26
Careers
EN
简
繁
About Us
Overview
Corporate Information
Board of Directors
Senior Management
Contact Us
Innovation Platform
Overview
R&D Approach
Our Pipeline
Key Corporate Partnerships
Innovation News
Commercial Platform
Overview
Competitive Advantages
Prescription Drugs
Consumer Health
Main Products
Commercial Platform News
News & Presentations
Recent News
All RNS & Press Releases
Presentations & Publications
Financial Results
Overview
Chairman's Statement
Financial Highlights
Financial Reports
SEC Filings
Shareholder Information
Overview
Events, Circulars & Forms
Share Price & Chart
Major Shareholders
Analyst Coverage
Dual-listing FAQs
Information for Shareholders
Warning to Shareholders
Terms of Reference & Policies
AIM Rule 26
Careers
Shareholder Information
Chi-Med
| Shareholder Information
Share Price Chart
London AIM:HCM
£2.99
+0.06 | 9 Apr 2020 | 08:01
Nasdaq AIM:HCM
US$18.49
+0.43 | 9 Apr 2020 | 16:00
Major Shareholders
Directors and Significant Shareholders
Events, Circulars and Forms
Annual General Meeting 2020
2020-04-27
Morgan Stanley Virtual Access Summit 2020
2020-03-23 - 2020-03-25
Deutsche Bank ADR Virtual Investor Conference (dbVIC)
2020-03-19
Investor FAQs
Frequently asked questions about Chi-Med's UK and US share listings
Information for Shareholders
Share-related address & contact information
AIM Rule 26 Disclosures
Disclosure reference pursuant to Rule 26 'Company Information' of the AIM Rules of Companies
Warning to Shareholders
Avoiding share fraud
Analyst Coverage
Bloomberg
Cantor Fitzgerald
Goldman Sachs
Barclays
Bank of America Merrill Lynch
Canaccord Genuity
CLSA
Deutsche Bank
Edison
HSBC
Macquarie
Morgan Stanley
Panmure Gordon
Trinity Delta